Gary Lepow, DPM
Podiatrist · Houston, TXNPI 1114905510
Payments from drug & device makers
What this record shows
This record is dominated by other: $886,451 of the $1,003,209 with a category attached, or 88.4%. Linvatec Corporation accounts for 91.5% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2022 at $803,886 and has fallen 99.0% since, to $8,221 in 2025. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 205 payments — averaging $4893.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Linvatec Corporation$918K
- In2bones USA, LLC$62K
- Stryker$13K
- Medinc Of Texas$4K
- Heron Therapeutics, Inc.$1K
- Musculoskeletal Transplant Foundation Inc.$912
- plus $4K from 29 others
What the payments were for
- Royalty or licence$65,1616%
- Consulting fees$28,2053%
- Speaking & faculty fees$4,0380%
- Grants$1,0000%
- Travel & lodging$9,7331%
- Food & beverage$4,6260%
- Education$3,9930%
- Other$886,45188%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Linvatec Corporation | 30 | $917,707 |
| In2bones USA, LLC | 45 | $62,115 |
| Stryker(2 entities) | 54 | $13,369 |
| Medinc Of Texas | 7 | $3,844 |
| Heron Therapeutics, Inc. | 2 | $1,182 |
| Musculoskeletal Transplant Foundation Inc. | 7 | $912 |
| Arthrex | 3 | $830 |
| Trimed, Inc. | 3 | $582 |
| Kerecis Limited | 1 | $416 |
| Medline Industries LP | 5 | $266 |
| Paratek Pharmaceuticals, Inc. | 5 | $159 |
| Boston Scientific | 1 | $141 |
| Abbott | 2 | $140 |
| Smith+Nephew | 4 | $136 |
| Treace Medical Concepts, Inc. | 7 | $133 |
| Paragon 28, Inc. | 3 | $123 |
| Organogenesis Inc. | 1 | $114 |
| Misonix Inc | 2 | $100 |
| GRT US Holding, Inc. | 1 | $98 |
| AbbVie | 2 | $96 |
| Janssen Scientific Affairs, LLC | 1 | $93 |
| Melinta Therapeutics, LLC | 2 | $73 |
| Amgen | 3 | $71 |
| Crossroads Extremity Systems, LLC | 1 | $71 |
| Bard Peripheral Vascular, Inc. | 1 | $62 |
| TEI Medical Inc. | 1 | $58 |
| Biotissue Holdings Inc. | 1 | $58 |
| Integra Lifesciences Corporation | 3 | $55 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $51 |
| Axogen | 1 | $44 |
| Baxter Healthcare | 1 | $32 |
| ERMI LLC | 1 | $26 |
| Averitas Pharma Inc. | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Zimmer Biomet | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVENGER RADIAL HEAD, +4 STEMS$886,451
- Reference Toe System$30,245
- AlloAid Allograft$19,418
- ALLOGRAFT TISSUE$17,102
- CoLink$13,780
- ALLOAID$11,795
- RTS FLEXIBLE 1ST MPJ IMPLANT W/GROMMETS$9,170
- IBS$7,272
- RTS$5,528
- FUTURA CSI$5,487
- FUTURA$4,539
- ClearGuard$2,602
- RTS FLEXIBLE 1ST MPJ IMPLANT WGROMMETS$2,403
- PRIME SERIES$1,408
- Zynrelef$1,182
- MIS Instrumentation$444
- Kerecis Omega3 Wound$416
- T2$339
- Dermatology and Wound Care$248
- ANCHORAGE$162
How this compares
$1,003,209 in reported general payments places this provider in the 95th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 50 | $211 |
| Terbinafine Hcl | 25 | $147 |
| Mupirocin | 13 | $145 |
| Gabapentin | 12 | $135 |
| Methylprednisolone | 22 | $113 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 14 | $105 |
| Naproxen | 21 | $54 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Houston
- Andrew SchneiderHouston$150K
- Randall BeckmanHouston$103K
- Jason ArmstrongHouston$91K
- Jerry MilesHouston$58K
- Tina OliverHouston$42K
- Lawrence MactavishHouston$41K
- Roberto de Los SantosHouston$33K
- Randal LepowHouston$33K
- Ava WashkoHouston$19K
- Jeffrey RossHouston$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.